Ceres Wins $430K from Gates for Ebola Test; Plans Near-term Launch of Lyme Disease Dx | GenomeWeb

NEW YORK (GenomeWeb) – Sample prep firm Ceres Nanosciences said this week it has received a $430,000 grant from the Bill & Melinda Gates Foundation for development work on a saliva-based test for the Ebola virus.

The grant will fund feasibility studies investigating the usefulness of Ceres' Nanotrap technology for preparation of saliva samples upfront of both nucleic acid and protein-based assays for the disease. The studies will be conducted in collaboration with George Mason University and the US Army Medical Research Institutes of Infectious Diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.